BelchJJF. Is there a role for natural remedies?Hung Rheumatol1991; 32: 14a.
2.
EngelJ-MJosenhansGHoderJBenzusG.Value of physical therapy from the viewpoint of the patient. Results of a questionnaire. Rheumatol1987; 46(5): 250–255.
3.
StoneE.An account of the success of the bark of the willow in the cure of agues. Philos Trans R Soc1763; 195: Chap33.
4.
HiggsGAPalmerRMJEakinsKEMoncadaS.Arachidonic acid metabolism as a source of inflammatory mediators and its inhibition as a mechanism of action for anti-inflammatory drugs. Molec Aspects Med1981; 4: 275–301.
5.
BelchJJFChopraMHutchinsonSLorimerRSturrockRDForbesCDSmithE.Free radical pathology in chronic arterial disease. Free Rad Biol Med1989; 6(4): 375–378.
6.
BelchJJF. Eicosanoids and rheumatology: Inflammatory and vascular aspects. In: Prostaglandins, Leukotrienes and Essential Fatty Acids Reviews1989; (4): 219–234.
7.
FullerWRKelseyCRColdPJDolleryCTMacDermotJ.Dexamethasone inhibits the production of thromboxane B2 and leukotriene B4 by human alveolar and peritoneal macrophages in culture. Clin Sci1984; 67: 653–656.
8.
MoilanenEAlankoJAsmawiMZVapaataloH.CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytes in-vitro. Eicosanoids1988; 1: 35–39.
9.
HepinstallH.Feverfew — An ancient remedy for modern times?J Royal Soc Med1988; 81: 373–374.
10.
JohnsonESKadamNPHylandsDMHylandsPJ. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J1985; 291: 569–573.
11.
PattrickMHepinstallSDohertyM.Feverfew in rheumatoid arthritis: A double blind, placebo controlled study. Ann Rheum Dis1989; 48: 547–549.
12.
BelchJJFLoweGDOMeekDForbesCDPrenticeCRM. Subcutaneous ancrod in the prophylaxis of deep vein thrombosis in patients undergoing hip replacement surgery. Thrombos Res1982; 25: 23–31.
13.
RainsfordKDWhitehouseMW. Gastroprotective and anti-inflammatory properties of Green lipped Mussels (Perna canaliculus) preparation. Drug Res1980; 2128–2132.
14.
HuskissonECScottJBryansR.Seatone is ineffective in rheumatoid arthritis. Br Med J1981; 282: 1358.
15.
LarkinJGCapellHASturrockRD. Seatone in rheumatoid arthritis: A six-month placebo-controlled study. Ann Rheum Dis1985; 44: 199–201.
16.
TullekenJELimburgPCMuskietFAvan RijswijkMH. Vitamin E status during dietary fish oil supplementation in rheumatoid arthritis. Arthritis Rheum1990; 33(3): 1416–1419.
17.
YutingCRongliangZZhongjianJYongJ.Flavinoids as superoxide scavengers and antioxidants. Free Rad Biol Med1990; 9: 19–21.
18.
BelchJJFAnsellDMadhokRO'DownASturrockRD. Effects of altering dietary essential fatty acids on requirements for non-steroidal and anti-inflammatory drugs in patients with rheumatoid arthritis: A double-blind placebo controlled study. Ann Rheum Dis1988; 47: 96–104.
19.
KremerJMBigaouetteJMichaelekAVTimchalkMALiningerLRynesRIHuyckCZieminiskiJBartholomewLE. Effects of manipulations of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet1985; 1: 184–187.
20.
KremerJMJubizWMichalekARynesRIBartholomewLEBigaouetteJTimchalkMABeckerDLiningerL.Fish-oil fatty acid supplementation in active rheumatoid arthritis. Lancet, 1987; 106(4): 497–502.
21.
LauCMorleyKMcMahonHBelchJJF. Maxepa reduced non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis. Hung Rheumatol1991; 32: 126a.
22.
MiehleW.Controversial and so-called alternative therapeutic approachesZ Rheumatol1987; 46(1): 1–12.